Protein Tagging System Offers New Directions for Heart and Vascular Therapies
en-GBde-DEes-ESfr-FR

Protein Tagging System Offers New Directions for Heart and Vascular Therapies

17/11/2026 Compuscript Ltd


A review published in Genes & Diseases highlights how the machinery that tags and manages proteins could offer new directions for treating cardiovascular disease. Researchers at the Affiliated Hospital of Zunyi Medical University examine the ubiquitin system and its influence on heart muscle injury, blood vessel inflammation, abnormal heart rhythms, and hypertension.

Ubiquitination involves attaching a protein called ubiquitin to other proteins. These tags can mark damaged or unwanted proteins for destruction, but they also regulate signalling and cellular activity. Enzymes called E3 ubiquitin ligases help select which proteins receive the tags, while deubiquitinating enzymes can remove them, creating a reversible control system.

The review brings together evidence across atherosclerosis, injury associated with restoring blood flow after cardiac ischemia, cardiac remodelling, arrhythmias, and high blood pressure. It explains how disrupted protein regulation can alter heart cell survival, activate scar-forming fibroblasts, and change the behaviour of immune cells and vascular smooth muscle cells.

One finding is that ubiquitination can either protect cardiovascular tissues or contribute to disease. Removing harmful proteins may reduce injury, whereas degrading protective proteins can intensify inflammation or impair heart function. The effects depend on the enzyme involved, its protein targets, the cell type, and the timing of intervention.

In experimental studies discussed in the review, the enzyme USP25 helped preserve SERCA2a, a protein important for calcium handling in heart cells. This stabilisation reduced pathological heart muscle enlargement in animal models, illustrating how selective manipulation of protein turnover could support cardiac protection.

The article also examines connections between ubiquitination and other protein modifications, including phosphorylation and acetylation. These interacting processes shape stress responses, mitochondrial quality control, inflammation, and fibrosis. Understanding their coordination could help researchers identify precise treatment targets.

Potential strategies include selective enzyme modulators and targeted protein degradation technologies such as PROTACs and molecular glues. These approaches aim to influence particular proteins rather than broadly disrupting cellular protein management. Their cardiovascular applications still require tissue-specific delivery and validation in humans.

Safety remains a consideration. Broad proteasome inhibitors used in cancer treatment have caused clinically significant heart toxicity, demonstrating the risks of interfering with a system essential to normal cellular function. Overlapping enzyme activities and shared protein targets also complicate drug development.
# # # # # #
Genes & Diseases publishes rigorously peer-reviewed and high quality original articles and authoritative reviews that focus on the molecular bases of human diseases. Emphasis is placed on hypothesis-driven, mechanistic studies relevant to pathogenesis and/or experimental therapeutics of human diseases. The journal has worldwide authorship, and a broad scope in basic and translational biomedical research of molecular biology, molecular genetics, and cell biology, including but not limited to cell proliferation and apoptosis, signal transduction, stem cell biology, developmental biology, gene regulation and epigenetics, cancer biology, immunity and infection, neuroscience, disease-specific animal models, gene and cell-based therapies, and regenerative medicine.
Scopus CiteScore: 10.4 |Impact Factor:14.6
# # # # # #
More information: https://www.keaipublishing.com/en/journals/genes-and-diseases/
Editorial Board: https://www.keaipublishing.com/en/journals/genes-and-diseases/editorial-board/
All issues and articles in press are available online in ScienceDirect (https://www.sciencedirect.com/journal/genes-and-diseases).
Submissions to Genes & Diseases may be made using Editorial Manager (https://www.editorialmanager.com/gendis/default.aspx).
Print ISSN: 2352-4820
eISSN: 2352-3042
CN: 50-1221/R
Contact Us: editor@genesndiseases.cn
X (formerly twitter): @GenesNDiseases (https://x.com/GenesNDiseases)
# # # # # #
Reference
Jingjing Zhu, Zhimei Qiu, Yi Xu, Qing Guo, Shuangya Yang, Yongchao Zhao, Bei Shi, The ubiquitin system in heart and vessel pathobiology: From mechanisms to therapeutic strategies, Genes & Diseases, Volume 13, Issue 6, 2026, 102023, https://doi.org/10.1016/j.gendis.2025.102023

Funding
National Natural Science Foundation of China 82470291
National Natural Science Foundation of China 82460055
Jingjing Zhu, Zhimei Qiu, Yi Xu, Qing Guo, Shuangya Yang, Yongchao Zhao, Bei Shi, The ubiquitin system in heart and vessel pathobiology: From mechanisms to therapeutic strategies, Genes & Diseases, Volume 13, Issue 6, 2026, 102023, https://doi.org/10.1016/j.gendis.2025.102023
Fichiers joints
  • Image Caption: Timeline of the research process on ubiquitination.
  • Image Caption: The regulatory process of ubiquitination.
  • Image Caption: The role of ubiquitination in cardiovascular disease.
17/11/2026 Compuscript Ltd
Regions: Europe, Ireland, Asia, China
Keywords: Health, Medical

Disclaimer: AlphaGalileo is not responsible for the accuracy of content posted to AlphaGalileo by contributing institutions or for the use of any information through the AlphaGalileo system.

Témoignages

We have used AlphaGalileo since its foundation but frankly we need it more than ever now to ensure our research news is heard across Europe, Asia and North America. As one of the UK’s leading research universities we want to continue to work with other outstanding researchers in Europe. AlphaGalileo helps us to continue to bring our research story to them and the rest of the world.
Peter Dunn, Director of Press and Media Relations at the University of Warwick
AlphaGalileo has helped us more than double our reach at SciDev.Net. The service has enabled our journalists around the world to reach the mainstream media with articles about the impact of science on people in low- and middle-income countries, leading to big increases in the number of SciDev.Net articles that have been republished.
Ben Deighton, SciDevNet
AlphaGalileo is a great source of global research news. I use it regularly.
Robert Lee Hotz, LA Times

Nous travaillons en étroite collaboration avec...


  • The Research Council of Norway
  • SciDevNet
  • Swiss National Science Foundation
  • iesResearch
Copyright 2026 by DNN Corp Terms Of Use Privacy Statement